智通财经APP获悉，Sage Therapeutics (SAGE.US)周二宣布阿尔茨海默病治疗药物dalzanemdor ...

In recent trading, Lightwave Logic Inc (LWLG) stock price has shown some volatility, fluctuating 8.55% over the last five trades and 11.88% over the past 30 trades. This represents a notable shift ...

科罗拉多州英格尔伍德 - 专门从事杂项塑料产品的Lightwave Logic, Inc. (NASDAQ:LWLG)公司报告称,其独立注册会计师事务所发生了变更。周一,Morison Cogen LLP辞去了其职务,公司审计委员会已任命Stephano Slack LLC为新的认证会计师。 Morison的辞职于2024年9月30日生效,这并非由于对2023年和2022财年财务报表的任何不利意见 ...

Sage Therapeutics’ share price fell 11% to $6 in pre-market activity on Tuesday, after it announced disappointing top-line ...

周二，Oppenheimer调整了对Sage Therapeutics (NASDAQ:SAGE)的展望，将目标价从之前的10美元下调至9美元，同时维持对该股的"表现"评级。这一调整是在Sage宣布其药物dalzanemdor未能在评估阿尔茨海默病相关轻度认知障碍（AD-MCI）患者治疗的2期LIGHTWAVE研究中达到主要目标之后做出的。 LIGHTWAVE研究的结果被视为一个挫折，尽管在该药物 ...

(RTTNews) - Sage Therapeutics, Inc. (SAGE) Tuesday said its Phase 2 LIGHTWAVE study to evaluate dalzanemdor in participants with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's ...

Sage has decided to discontinue the development of dalzanemdor in Alzheimer’s disease. A study of the candidate in Huntington ...

Lightwave Logic, Inc. (NASDAQ:LWLG) is no longer a reflexivity case to the extent that the general market isn't in a bearish spot, and they are moving to raise capital at fine prices. Revenues ...

Shares of Sage Therapeutics, Inc. SAGE were down 4.3% on Oct. 8 after the company announced disappointing top-line data from ...

智通财经APP获悉，Sage Therapeutics (SAGE.US) 周二宣布阿尔茨海默病治疗药物dalzanemdor ...

Lightwave Logic, Inc. (NASDAQ: LWLG), a technology platform company leveraging its proprietary electro-optic (EO) polymers to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...